Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 205 of the 222 references it cites were found in a registry or an index; 39 of the 219 sources its claims cite were checked for support.
Abstract
OBJECTIVE: This clinical practice guideline addresses the diagnosis and treatment of primary adrenal insufficiency. PARTICIPANTS: The Task Force included a chair, selected by The Clinical Guidelines Subcommittee of the Endocrine Society, eight additional clinicians experienced with the disease, a methodologist, and a medical writer. The co-sponsoring associations (European Society of Endocrinology and the American Association for Clinical Chemistry) had participating members. The Task Force received no corporate funding or remuneration in connection with this review. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to determine the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: The evidence used to formulate recommendations was derived from two commissioned systematic reviews as well as other published systematic reviews and studies identified by the Task Force. The guideline was reviewed and approved sequentially by the Endocrine Society's Clinical Guidelines Subcommittee and Clinical Affairs Core Committee, members responding to a web posting, and the Endocrine Society Council. At each stage, the Task Force incorporated changes in response to written comments. CONCLUSIONS: We recommend diagnostic tests for the exclusion of primary adrenal insufficiency in all patients with indicative clinical symptoms or signs. In particular, we suggest a low diagnostic (and therapeutic) threshold in acutely ill patients, as well as in patients with predisposing factors. This is also recommended for pregnant women with unexplained persistent nausea, fatigue, and hypotension. We recommend a short corticotropin test (250 μg) as the "gold standard" diagnostic tool to establish the diagnosis. If a short corticotropin test is not possible in the first instance, we recommend an initial screening procedure comprising the measurement of morning plasma ACTH and cortisol levels. Diagnosis of the underlying cause should include a validated assay of autoantibodies against 21-hydroxylase. In autoantibody-negative individuals, other causes should be sought. We recommend once-daily fludrocortisone (median, 0.1 mg) and hydrocortisone (15-25 mg/d) or cortisone acetate replacement (20-35 mg/d) applied in two to three daily doses in adults. In children, hydrocortisone (∼8 mg/m(2)/d) is recommended. Patients should be educated about stress dosing and equipped with a steroid card and glucocorticoid preparation for parenteral emergency administration. Follow-up should aim at monitoring appropriate dosing of corticosteroids and associated autoimmune diseases, particularly autoimmune thyroid disease.
Overview
CoChat Summary
TL;DR
This Endocrine Society clinical practice guideline provides evidence-based recommendations for diagnosing and treating primary adrenal insufficiency (PAI), emphasizing a low diagnostic threshold, the 250-µg short corticotropin test as the diagnostic gold standard, and glucocorticoid/mineralocorticoid replacement with adrenal crisis prevention. It also highlights major evidence gaps, including sparse randomized trial data for replacement regimens and limited diagnostic accuracy studies specifically in PAI.
Key findings
- For diagnosis, the guideline recommends testing patients with indicative symptoms/signs and using the standard-dose 250-µg corticotropin stimulation test as the “gold standard”; peak cortisol below 500 nmol/L (18 µg/dL) at 30 or 60 minutes indicates adrenal insufficiency. The high-dose ACTH stimulation test had a sensitivity of 92% (95% CI, 81–97%) for PAI based on five studies; no studies were available for the low-dose test in PAI. If corticotropin testing is not feasible, a morning cortisol <140 nmol/L (5 µg/dL) plus ACTH is suggested as a preliminary test.
- Autoimmune adrenalitis is the most common cause of PAI, accounting for up to 90% in Western countries; 21-hydroxylase autoantibodies should be measured, and about 30% of CYP21A2 autoantibody-positive individuals progressed to overt PAI during 5-year follow-up. In autoantibody-negative individuals, other causes should be sought, including adrenoleukodystrophy in males via very-long-chain fatty acids and adrenal CT for infiltrative or malignant disease.
- In adults, recommended replacement is hydrocortisone 15–25 mg/d or cortisone acetate 20–35 mg/d in two or three divided doses, with fludrocortisone starting at 50–100 µg/d (median, 0.1 mg) for confirmed aldosterone deficiency. Prednisolone 3–5 mg/d is an alternative, while dexamethasone is suggested against. DHEA replacement may be tried for 6 months in women with low libido, depressive symptoms, and/or low energy despite optimized replacement.
- For adrenal crisis, immediate parenteral hydrocortisone 100 mg (50 mg/m² for children) is recommended, followed by 200 mg/24 h (50–100 mg/m²/d for children), plus fluid resuscitation. Reported adrenal crisis frequencies were 6.6 crises/100 patient-years in a retrospective analysis of 444 patients and 8.3 crises/100 patient-years in a prospective study of 768 patient-years, with a crisis mortality rate of 0.5/100 patient-years.
Methods
- This is a GRADE-based clinical practice guideline developed by an Endocrine Society Task Force with a methodologist and medical writer; recommendations are graded strong (“we recommend,” 1) or weak (“we suggest,” 2), with evidence quality from QEEE (very low) to QQQQ (high), plus ungraded best practice statements.
- Evidence came from two commissioned systematic reviews and other published systematic reviews/studies. The first review compared high-dose vs low-dose ACTH stimulation for diagnosis and found only five studies for high-dose ACTH in PAI and none for low-dose ACTH in PAI. The second review compared glucocorticoid replacement regimens and identified 15 observational studies; mortality, bone density, and adrenal crisis data were very sparse or unavailable, and there was no statistically significant HRQoL difference between hydrocortisone dosages ≥30 mg/d vs <30 mg/d.
- The guideline was reviewed and approved sequentially by Endocrine Society committees, members responding to a web posting, and the Endocrine Society Council; the Task Force received no corporate funding or remuneration.
Limitations
- The paper states that the evidence base is limited: there are no randomized controlled trials for many treatment questions, diagnostic accuracy data for high-dose ACTH in PAI come from only five studies with none for low-dose ACTH in PAI, and the second systematic review found sparse or unavailable data on mortality, bone density, and adrenal crisis, with very low-quality evidence for extended-release/dual-release glucocorticoids. Many recommendations are weak or ungraded best practice statements.
- The paper states that cortisol cutoff values after corticotropin stimulation vary by assay, ACTH assays have analytical bias, and actual clinical cutpoints should be based on assay-specific normative data.
- Evident from the text: the guideline focuses only on PAI and explicitly excludes secondary adrenal insufficiency and critical illness-related corticosteroid insufficiency; some recommendations rely on clinical experience, unsystematic observations, and values/preferences rather than direct systematic evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Algorithm for the diagnostic approach to the patient with PAI. The most common causes of PAI are autoimmune destruction of the adrenal cortex in adults and CAH in children. These etiologies can be screened for using 21-hydroxylase antibodies and a baseline serum 17hydroxyprogesterone level. Males with negative 21-hydroxylase antibodies should be tested for adrenoleukodystrophy with plasma VLCFAs. If these diagnoses are excluded, a CT scan of the adrenals may reveal evidence of adrenal infiltrative processes or metastases. The individual's clinical picture and family history may render some steps in the algorithm redundant or suggest specific genetic syndromes. The latter includes subtypes of autoimmune polyglandular syndromes or specific rare genetic disorders where adrenal failure is part of a broader phenotype. A list of differential diagnoses is provided in Table 2. AHC, adrenal hypoplasia congenita; AI, adrenal insufficiency; VLCFA, very long chain fatty acid. a 17-OHprogesterone > 1000 ng/dL is diagnostic for 21-OH deficiency (14). b VLCFA should be measured in the initial evaluation of preadolescent boys. [Adapted from E. S. Husebye, et al: Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med . 2014;275:104-115 (181), with permission. © John Wiley & Sons, Inc.]](https://figures.cochat.ai/paper-figures/3d28d00e3ab049b5b513e655fd2f1f7a/diagnosis-and-treatment-of-primary-adrenal-insufficiency-an-endocrine-society-figure-1.png)
Verification
Claims the paper makes
35 Valid · 2 Not valid · 109 Not checked · 48 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“However, in all these reports, adrenal crisis was a significant cause of death.”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Disputedcites [149] 149. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addison's disease: a pop- ulation-based study. J Clin Endocrinol Metab. 2006;91:4849 - 4853. sourceExperimental — accuracy not yet measured
The Mortality section reports 36 deaths attributed to adrenal insufficiency but explicitly says that no patient was reported to have died from adrenal crisis under ICD-10. It also cautions that ICD-9 cannot distinguish adrenal crisis from primary adrenal insufficiency, so the study does not establish crisis as a significant cause of death. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [150] 150. Bensing S, Brandt L, Tabaroj F, et al. Increased death risk and altered cancer incidence pattern in patients with isolated or com- bined autoimmune primary adrenocortical insufficiency. Clin En- docrinol (Oxf). 2008;69:697-704. source
- Not checked — no full text of the sourcecites [7] 7. Erichsen MM, Løvås K, Fougner KJ, et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of prema- ture death. Eur J Endocrinol. 2009;160:233-237. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In addition to a paired sample of cortisol and ACTH, the adrenal reserve is appropriately and safely assessed in pregnancy by corticotropin stimulation, if indicated (40,41).”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Supportedcites [40] 40. Lebbe M, Arlt W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol (Oxf). 2013;78:497-502. source
The Investigations section (p. 3) calls the short Synacthen test a valid measure of adrenal cortisol reserve, including in pregnancy, and says there is no medical reason to avoid a single diagnostic dose in a pregnant woman. The Summary (p. 1) recommends the test when clinically feasible, alongside paired cortisol and ACTH measurements. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [41] 41. Suri D, Moran J, Hibbard JU, Kasza K, Weiss RE. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test. J Clin Endocrinol Metab. 2006;91:3866 -3872. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Patients with diseases such as nephrotic syndrome (43) and liver disease (50) as well as those who are in the immediate postoperative period (51) or who require intensive care (52) may have lower CBG and albumin and hence, lower cortisol measurements.”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Not checked — no full text of the sourcecites [43] 43. Klose M, Lange M, Rasmussen AK, et al. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocri- nol Metab. 2007;92:1326 -1333. source
- Not checked — no full text of the sourcecites [50] 50. Vincent RP, Etogo-Asse FE, Dew T, Bernal W, Alaghband-Zadeh J, le Roux CW. Serum total cortisol and free cortisol index give different information regarding the hypothalamus-pituitary-adre- nal axis reserve in patients with liver impairment. Ann Clin Biochem. 2009;46:505-507. source
- Supportedcites [51] 51. le Roux CW, Chapman GA, Kong WM, Dhillo WS, Jones J, Alagh- band-Zadeh J. Free cortisol index is better than serum total cortisol in determining hypothalamic-pituitary-adrenal status in patients undergoing surgery. J Clin Endocrinol Metab. 2003;88:2045- 2048. source
For the part attributed to this source—the immediate postoperative period—the Results report that albumin and CBG fell after surgery, and that seven patients had unexpectedly low postoperative total cortisol. The Discussion attributes those low cortisol values to the fall in CBG. The other conditions in the citing sentence have separate citations. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [52] 52. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004;350: 1629 -1638. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Interpretation of the diagnostic results requires thorough consideration of pregnancy-associated physiological changes of adrenocortical function (42).”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Supportedcites [42] 42. Jung C, Ho JT, Torpy DJ, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab. 2011;96:1533-1540. source
The Discussion (page not specified in the supplied passage) says that physiological hypercortisolism can be difficult to distinguish from Cushing’s syndrome during pregnancy and emphasizes trimester-specific reference ranges. This supports considering pregnancy-related adrenocortical changes when interpreting diagnostic results. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“An elevated ACTH concentration in the presence of a cortisol in the normal range can be the first sign of early-stage PAI (68).”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Could not verifycites [68] 68. Baker PR, Baschal EE, Fain PR, et al. Haplotype analysis discrim- inates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. J Clin Endo- crinol Metab. 2010;95:E263-E270. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that 21-hydroxylase autoantibodies usually precede overt Addison’s disease and proposes subsequent adrenal-function testing. Neither that passage nor the passages retrieved by searching for ACTH, cortisol, and early adrenal insufficiency addresses whether elevated ACTH with normal-range cortisol can be an early sign of PAI. (LLM, conf=0.73)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
118 more claims · 24 with their cited sources checked
Create a free account to see all 194 claims and every source verdict.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 58
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In children, glucocorticoid replacement therapy (GCCrt) should be started with hydrocortisone (HC) at a total daily dose of 10 mg/m2, with dose titration according to individual needs (35).”
From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“no drug suitably mimics the diurnal pattern of cortisol”
From Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells (2018) · cites this paper as Bornstein et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In such cases, a GC dosage increase of 20% to 40% from the 24th week onward is often beneficial (215).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [215]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, no consensus exists regarding the optimal dose and hydrocortisone delivery mode during major stress, and current recommendations are empirical rather than evidence-based (7, 17).”
From Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery (2020) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In primary and secondary adrenal insufficiency, peak cortisol levels < 500 nmol/L (< 18.1 μg/dL), depending on assay, are indicative of adrenal insufficiency (38, 39).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [38]
Experimental — accuracy not yet measured
25 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > 2.2
“We suggest the low-dose (1 g) corticotropin test for diagnosis of PAI only when the substance itself is in short supply.”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
“Thus, for practical reasons, the low-dose test may be applicable to situations when corticotropin is in short supply or for other structural or economic reasons.”
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group, an international group with expertise in development of evidence-based guidelines (15).”
MethodSapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Enhanced glucocorticoid secretion in critical illness is considered necessary to prevent defense mechanisms (eg, cytokine release) from overshooting with concomitant detrimental toxicity (142, 143).”
BackgroundSapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · cited 1×
“In newborns and children, mineralocorticoid sensitivity is lower, thereby usually requiring higher fludrocortisone doses compared to adults (106).”
BackgroundSpeiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 4×
“a 17-OHprogesterone 1000 ng/dL is diagnostic for 21-OH deficiency (14).”
BackgroundMethodInfluentialSelf-citationORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349 · cited 1×
“Serum DHEAS concentrations physiologically peak between ages 20 and 30 years, followed by a gradual decline that is independent of menopause (113).”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationCorticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Marik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912 · cited 1×
“Although similar arguments for the utility of the low-dose test have been proposed for other special diagnostic challenges such as the detection of adrenal insufficiency in critically ill patients (critical illness-related corticosteroid insufficiency), more evidence is needed to support such a formal recommendation (…”
BackgroundSelf-citationPharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886 · cited 1×
“Because of the short plasma half-life of hydrocortisone (approximately 90 min) (90), multiple dosing is recommended to mimic physiological conditions.”
Background
Research works printed but not linked: 3
- [29]29. Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insuffi- ciency. Ann Intern Med. 2003;139:194 -204.
- [110]110. Keilholz U, Guthrie GP Jr. Adverse effect of phenytoin on miner- alocorticoid replacement with fludrocortisone in adrenal insuffi- ciency. Am J Med Sci. 1986;291:280 -283.
- [177]177. Gan EH, MacArthur K, Mitchell AL, et al. Residual adrenal func- tion in autoimmune Addison's disease: improvement after tetra- cosactide (ACTH1-24) treatment. J Clin Endocrinol Metab. 2014; 99:111-118.
Cited by
Items 1,601–1,700 of 1,752
Additional file 1 of Genetic aetiology of primary adrenal insufficiency in Chinese children
Chang, Z., Lu, W., 赵诸慧, Li, X., Li, X., Ye, R., 倪锦文, Zhou, P., Zhang, M., Cheng, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14889528
Manosroi, W., Atthakomol, P., Inthaphan, P., & Hintong, S. (2024) · Figshare · doi:10.6084/m9.figshare.25405986
Additional file 7 of Genetic aetiology of primary adrenal insufficiency in Chinese children
Chang, Z., Lu, W., 赵诸慧, Xi, L., Li, X., Ye, R., 倪锦文, Zhou, P., Zhang, M., Cheng, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14889546
Manosroi, W., Atthakomol, P., Inthaphan, P., & Hintong, S. (2024) · Figshare · doi:10.6084/m9.figshare.25406096
Additional file 1 of Performance of synacthen test in chronic hemodialysis patients
Nickler, M., Stampf, S., Bernasconi, L., Segerer, S., Blum, C. A., & Kim, M. J. (2023) · Figshare · doi:10.6084/m9.figshare.24522609
Additional file 6 of Genetic aetiology of primary adrenal insufficiency in Chinese children
Chang, Z., Lu, W., 赵诸慧, Li, X., Li, X., Ye, R., 倪锦文, Zhou, P., Zhang, M., Cheng, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14889543
Additional file 2 of Genetic aetiology of primary adrenal insufficiency in Chinese children
Chang, Z., Lu, W., 赵诸慧, Xi, L., Li, X., Ye, R., 倪锦文, Zhou, P., Zhang, M., Cheng, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14889531
Additional file 5 of Genetic aetiology of primary adrenal insufficiency in Chinese children
Chang, Z., Lu, W., 赵诸慧, Xi, L., Li, X., Ye, R., 倪锦文, Zhou, P., Zhang, M., Cheng, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14889540
Endocrine Toxicities Related to Immunotherapy
Quinn, M. A., Carroll, P., & Joshi, M. N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00775-9_348
Lee, J. P. (2025) · Springer eBooks · doi:10.1007/978-3-032-07080-7_7
A CLINICAL CASE OF ATYPICAL PRESENTATION OF ADDISON’S DISEASE
Mokhort, T., Баалбаки, Д. Д., & Kuzmiankova, A. (2025) · Medical Journal · doi:10.51922/1818-426x.2025.4.148
Прогнозирование риска развития надпочечниковой недостаточности после унилатеральной адреналэктомии
Чулков, А. А., Дундаров, З. А., Величко, А. В., & Мартинков, В. Н. (2025) · Хирургия Восточная Европа · doi:10.34883/pi.2025.14.4.021
Drug Repurposing for Autoimmune Disorders
Singh, N., Kanaujia, K. A., Verma, A., Alka, & Mishra, N. (2026) · Springer eBooks · doi:10.1007/978-981-95-4522-3_5
Minimally Invasive Adrenalectomy: The Technical Steps of the Laparoscopic and Robotic Approaches
Şambel, M., Kılıç, Ş., & Ateş, M. (2025) · Springer eBooks · doi:10.1007/978-3-032-00010-1_15
Development of an experimental model for vascularized adrenal gland transplantation in rats
Özcan, C., Hazinedaroglu, S. M., & Tuğ, T. (2026) · Frontiers in Surgery · doi:10.3389/fsurg.2025.1749069
Zacharia, S. S., Cherian, K. E., Thomas, R., & Paul, T. V. (2026) · Indian Journal of Physical Medicine and Rehabilitation · doi:10.4103/ijpmr.ijpmr_46_25
Intensive Care Manual 2025 Edition for Patients with Irreversible Total Cerebral Dysfunction
黒田, 泰., 土井, 研., 横堀, 將., et al. (2026) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.33_s1
Addison’s Disease Presenting with Hypercalcaemia, Acute Kidney Injury, and Anxiety
Tshering, S., Qayyum, W., & Kapoor, A. (2026) · Cureus · doi:10.7759/cureus.101663
“Apart from salt craving, symptoms of PAI are generally non-specific, such as weakness, fatigue, pain, weight loss, abdominal discomfort, depression, and anxiety, which often lead to delayed diagnosis and presentation as a potentially life-threatening adrenal crisis [6].”
InfluentialKono, T., Miyagawa, H., Kawauchi, Y., Taki, Y., Sakuma, I., Hashimoto, N., Oki, Y., Shimatsu, A., & Tanaka, T. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.01.006
“5,6 On the day of induction, stress-dose hydrocortisone (100 mg intravenously at labor Highlights • Central hypothyroidism: titrate levothyroxine to the upper-normal free thyroxine range because thyroid-stimulating hormone is unreliable; make small trimester-appropriate adjustments, and reassess…”
The Clinical Impact of Corticosteroid Supplementation in Febrile Patients with Adrenal Insufficiency
Kwon, H., Lee, S. E., Park, J. H., Ko, J. W., & Kim, B. (2026) · Yonsei Medical Journal · doi:10.3349/ymj.2025.0008
“16 Diagnosis under this cut-off may have inadvertently included borderline patients who had relatively preserved adrenal responses, as well as critically ill patients for whom the benefit of steroid supplementation remains controversial.”
Diagnostic pharmacology: Drugs that uncover diseases
Saranraj, K., & Chandana, G. P. S. (2025) · National Journal of Pharmacology and Therapeutics · doi:10.4103/njpt.njpt_46_25
Cushing syndrome in pediatrics: From molecular pathogenesis to therapeutic management
Nicolaides, N. C., & Stratakis, C. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00021-1
Self-citationEndocrine late-effects in survivors of childhood and adolescence cancer: clinical management
Biasin, E., Felicetti, F. C., Cattoni, A., Aloj, G., Giorgiani, G., Gorio, C., Haupt, R., Mastronuzzi, A., Muraca, M., Pillon, M., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02824-4 · Cited by 2
Patten, R. V., Hallowell, E. S., Kamper, J. E., Jennette, K. J., & Kanser, R. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-05880-5_7
Bridwell, R. E., & April, M. D. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2025.02.006
Czaplińska-Paszek, Z., Rynkiewicz, K., Bogusz, N., Paszek, S. P., & Zakrzewska, A. M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.4896
Hsiao, I.-T., & Lu, C.-H. (2026) · Cureus · doi:10.7759/cureus.103162
“Serious consequences like osteoporosis and mood changes were also prominent [19].”
Adrenal insufficiency: Etiology and diagnosis
Nicolaides, N. C., & Charmandari, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00338-1
Addisonian Crisis in a 39-Year-Old Woman With Primary Adrenal Insufficiency
Itteera, M., Gutierrez, M., & Patel, K. H. (2026) · Cureus · doi:10.7759/cureus.103607
“It is often precipitated by stressors such as infection, trauma, or non-adherence to medications [3,4].”
InfluentialAdrenal Disorders in Pregnancy
Mathew, J. T., & Yeung, A. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2025.12.003 · Cited by 1
Kim, M., Jung, H., Kim, S. B., Jeon, H., Chung, Y., Shim, Y., Kwon, S. M., Kim, J. H., Chung, J., Choi, K.-S., et al. (2026) · Critical Care · doi:10.1186/s13054-026-05915-z
“The diagnosis of CIRCI was established in accordance with the Endocrine Society’s clinical practice guidelines on adrenal insufficiency (AI) [19].”
Lecký, P., Péč, M. J., Turcan, M., Miertová, Z., Focko, B., Galajda, P., & Mokáň, M. (2026) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2026_006147
“Management of APS II is based on lifelong hormone replacement therapy for the affected glands, with adequate glucocorticoid and mineralocorticoid substitution forming the cornerstone of treatment [10] .”
Khalid, W., (14716756), M. U. K., Khoso, M., Zahid, N., Latif, N., & Hassan, A. (2026) · Cureus · doi:10.7759/cureus.104591
“Adrenal insufficiency, whether primary or secondary, can lead to cortisol and, in some cases, aldosterone deficiency, resulting in hemodynamic instability and metabolic disturbances that can affect the cardiovascular system [5].”
Weismann, D. (2026) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-026-01422-9
Adrenal Insufficiency in Adults
Abraham, S. B. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2025.12.001
Endocrine Modulation of Inflammation: The Role of Adrenocorticotropic Hormone and Cortisol
Vidal, M., & Lane, N. E. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.03.001
Lipid Profile in Primary Aldosteronism: Cross‐Sectional and Post‐Treatment Analyses
Yazidi, M., Abid, A., Sliman, C. B. H., Kamoun, E., Oueslati, I., Chaker, F., Khessairi, N., & Chihaoui, M. (2026) · Lipids · doi:10.1002/lipd.70051
“Exclusion criteria for both patients and controls included conditions known to affect lipid metabolism, such as chronic inflammatory, infectious, or neoplastic diseases; severe renal impairment (Glomerular filtration rate < 30 mL/min/1.73 m 2 ); hepatic failure; endocrine disorders associated with metabolic disturbanc…”
Influential(Primäre) Nebenniereninsuffizienz im Kindes- und Jugendalter
Kamrath, C., & VöLKL, T. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21447-9.50065-9
Choudhury, S., Lazarus, K., Sharma, A., Narula, K., Go, C., Cro, S., Thaventhiran, T., Khoo, B. C. E., Tan, T., & Meeran, K. M. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.2982 · Cited by 2
Prednisolone vs Hydrocortisone for Hypoadrenalism—An Uneven Battle
Boyanova, M. E. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.2995
Beyond the genome: clinical challenges in diagnosing LONP1-related mitochondrial disorders
Jiang, Q., Duan, J., Liu, C., Zhu, Y., Zeng, Q., Hu, Y., Luo, Z., Cao, D., Liao, J., & Chen, L. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1779332 · Cited by 1
“Moreover, the adrenal gland is an endocrine organ with high energy demands, and infection and stress have the potential to trigger adrenal crises (Bornstein et al., 2016).”
Lin, S., Li, J., Yang, W., Zhong, J., Zeng, X., Guo, P., & Wang, S. (2026) · Medicine · doi:10.1097/md.0000000000048154
“[19,20] This study further supports the conclusions of Bornstein et al [21] and Hannon et al [22] that low preoperative COR levels are associated with the risk of postoperative hyper-natremia, while suggesting that it may serve as an independent predictor of this complication.”
Yu, K., & Bancos, I. (2026) · Pituitary · doi:10.1007/s11102-026-01652-2
“Despite consensus guidelines, significant uncertainty per - sists regarding optimal glucocorticoid daily total dose, for - mulation, and dosing frequency [34].”
Iglesias, P. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2649164 · Cited by 1
“Patients with prolactin deficiency exhibit increased carotid intima–media thickness, reflecting subclinical atherosclerosis, and signs of endothelial dysfunction, such as impaired vascular flow, particularly in men with cabergoline-induced hypo-prolactinemia [127].”
InfluentialCo‐Creating an Adrenal Insufficiency Patient Toolkit Using Human‐Centered Design
Sinclair, A., Budiyanto, I., Ghosh, M., Mereu, L., Lam, A. P., Opgenorth, A., Campbell-Scherer, D., & Yeung, R. O. (2026) · International Journal of Endocrinology · doi:10.1155/ije/8410431
Kolli, V., Trick, J., Schulman, A., Iben, J., Padilla, C. J., Li, T., Faucz, F. R., & Merke, D. P. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1784619
Self-citationThe Newborn With a Suspected Difference of Sex Development
Grimstad, F. W., Keays, M. A., Schmedding, A., Schmedding, R., & Chan, Y.-M. (2026) · NeoReviews · doi:10.1542/neo.27-4-003
Ogata, Y., Bamba, M., Bamba, K., et al. (2026) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.70634
Felimban, A. A., Cavallé-Garrido, T., & Altit, G. (2026) · NeoReviews · doi:10.1542/neo.27-4-008
Hair cortisol as a marker of glucocorticoid replacement adequacy in adrenal insufficiency
Yilmaz, M. K., Tek, S., Kiliccioglu, G. K., Ozkahraman, A. U., Niyazoğlu, M., & Şuheda, H. E. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1765179
Das, B., Fatima, T., & Sheikh, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-12937-6_14
Hantelius, V., Johannsson, G., Jakobsson, S., Thurin, E., Hallén, T., Skoglund, T. S., & Ragnarsson, Ó. (2026) · Clinical Endocrinology · doi:10.1111/cen.70139
“If uncertainty, an intravenous cortico-trophin stimulation test was performed according to guidelines [12].”
Endocrine Disorders and Psychiatric Symptoms: A Comprehensive Overview
Concepción‐Zavaleta, M. J., Aldave, J. E. Q., Fuentes‐Mendoza, J. M., Durand‐Vásquez, M. D. C., Basurto-Ayala, A., Urteaga, L. A. C., Peralta, D. C., & Paz‐Ibarra, J. (2026) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-026-00381-4
Bille, D. (2026) · Journal of Case Reports and Clinical Studies · doi:10.46439/casereports.2.014
Kato, S., Akanuma, H., Nara, M., Sato, T., Morii, T., Fujita, H., & Waki, H. (2026) · Cureus · doi:10.7759/cureus.107059
“…and Treatment of Primary Adrenal Insufficiency, co-sponsored by the European Society of Endocrinology and the American Association for Clinical Chemistry, a peak cortisol level 18 µg/dL (500 nmol/L) is defined as the diagnostic threshold, although this cut-off is noted to be assay-dependent [3].”
Yamamoto, N., Ohta, R., Yamasaki, A., & Sano, C. (2026) · Cureus · doi:10.7759/cureus.107114
Bellastella, G., Nuzzo, M. D., Longo, M., Cirillo, P., Maio, A., Martino, N. D., Angelino, S., Caruso, P., Scappaticcio, L., Vietri, M. T., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70776
“Current clinical guidelines of Scientific Societies for autoimmune diseases (excluding primary adrenal insufficiency) do not provide specific recommendations for T1D screening in individuals with pre-existing autoimmune diseases or a family history of autoimmunity [28].”
Unmasking Adrenal Insufficiency: Adrenal Crisis Triggered by Influenza-Associated Encephalitis
Segev, N., Wilson, E., Moehlman, M., & Corathers, S. D. (2026) · PEDIATRICS · doi:10.1542/peds.2025-072983
Walfish, L., Feldman, L. S., Ajise, O., & Rivera, J. A. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag050
Turska, E., Lewandowski, K. C., Symonowicz, I., Kobus, M., Horzelski, W., Kubiatowski, T., Marchewka, J., & Kalinka, E. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1810229
van de Loo, I., & Harbeck, B. (2026) · Springer eBooks · doi:10.1007/978-3-662-71684-7_3
Bima, C., Campioni, L., Berton, A. M., Sola, C., Bergoglio, B., Carlo, M. C. D., Ponzetto, F., Settanni, F., Ceccato, F., Parasiliti‐Caprino, M., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02874-8
“The aetiology of adrenal insufficiency was assessed at diagnosis through measurement of anti 21-hydroxylase antibodies (21OHAbs), 17-hydroxyprogesterone, adrenal CT scan or very long chain fatty acids (VLCFAs) in males [4].”
InfluentialWang, M., Xu, Y., Dong, Z., & Song, Y. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02282-2
“Our clinical experience corroborates the 2016 Endocrine Society guidelines [12, 13], which advocate immediate high-dose glucocorticoids in suspected adrenal crisis, concurrent management of precipitating factors, and reducing dose gradually until clinical stability.”
Franco, L. A. C., Villamizar, M., Caceres, C. L., et al. (2026) · Cureus · doi:10.7759/cureus.107884
Perioperative Management of Patients Receiving Immune Checkpoint Inhibitors
Yadav, P., Goswami, J., & Garg, R. (2026) · Journal of onco-anaesthesiology and perioperative medicine. · doi:10.4103/joapm.joapm_79_25
Alenezi, G. E. K., Alqahtani, N., & Alsabaan, F. (2026) · Journal of Clinical Practice and Medical Research · doi:10.59324/jcpmr.2026.2(3).02
Nokoff, N., Fechner, P. Y., Kim, M. S., Marshall, I. H., Merke, D. P., Sarafoglou, K., Hartzell, A. L., Lin, V. H., & Thornton, P. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag192
Self-citationA case of autoimmune encephalitis with autoimmune gastritis presenting as refractory hyponatremia
Sun, W., Wang, C., Wang, Y., et al. (2026) · BMC Neurology · doi:10.1186/s12883-026-04920-7
“Although lower limb involvement is less typical in classical FBDS, the stereotyped, brief, high-frequency nature of these episodes, occurring without Central adrenal insufficiency is most often secondary to organic or functional disorders affecting the hypo-thalamic-pituitary region [3].”
Pan, R., Chen, T., Guo, G. D., Chang, S., Zhou, J., Niu, P., Zeng, X., & Zhang, J. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02901-8
Götz, H., & Amrein, K. (2026) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2026.04.002
Berruti, A., Cosentini, D., Laganà, M., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.05.009
Hu, C., Cui, Z., Dou, Y., & Yuan, B. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05426-2 · Cited by 1
Rare Causes of Pediatric Primary Adrenal Insufficiency: An Observational Cohort Study
Schermesser-Sicard, M., Samara‐Boustani, D., Roucher‐Boulez, F., Pinto, G., Carel, J., Quoc, A. N., Vermillac, G., Rovani, S., Thalassinos, C., Costa, S., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.05.011 · Cited by 1
Störungen des Cortisol-Haushaltes
Osswald-Kopp, A. (2026) · CME · doi:10.1007/s11298-026-4573-8
Antituberculosis Chemotherapy for Extrapulmonary Tuberculosis (EPTB)
Singh, P., Govindaswamy, A., Agarwal, K., Ahmed, M. N., & Kumar, S. (2026) · Springer eBooks · doi:10.1007/978-981-92-0256-0_3
Talib, A. M., Azhari, A., Abozinadah, Y. M., et al. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.108320
Congenital adrenal hyperplasia
Vorontsova, M. V., Кокорина, Т. С., Nuralieva, N. F., Yukina, M. Y., Troshina, E., Mel'nichenko, G. A., & Mokrysheva, N. G. (2026) · Problems of Endocrinology · doi:10.14341/probl13763
Weismann, D. (2026) · Notfall + Rettungsmedizin · doi:10.1007/s10049-026-01772-z
li, Q., Zhao, L., Huang, F., gong, X., Pan, M., Liu, X., Wang, T., Li, X., Xie, Y., Gao, A., et al. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02322-x
Kanamitsu, Y., Seino, Y., Toyoda, N., Sugiura, Y., Takano, T., Kunishima, H., Sato, Y., Izumo, M., & Fujitani, S. (2026) · Case Reports in Critical Care · doi:10.1155/crcc/6331364
“Moreover, the typical biochemical hallmarks of primary adrenal insufficiency (hyponatremia, hyperkalemia, eosinophilia, and low cortisol with high ACTH) may be obscured by fluid resuscitation, renal replacement therapy, or concomitant medications [4, 5].”
Brain and Endocrine Crosstalk: Clinical Implication for Neurocritical Care
Tulskii, I., Kulikov, A., & Savin, I. (2026) · Physiology in clinical neurosciences · doi:10.1007/978-981-92-0763-3_13
Shewale, H., & Patil, A. (2026) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2026.04.002
Chiloiro, S., Sanctis, S. A. D., Parente, B., Giampietro, A., D’Angelo, T., Palluzzi, E., Rossi, E., Vertechy, L., Vita, E., Paris, I., et al. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10058-1
Montafia, I., Dimarakis, S., Partenope, C., Rabbone, I., Bellone, S., Petri, A., Mellone, S., Giordano, M., & Prodam, F. (2026) · Genes · doi:10.3390/genes17060640
Li, H., Cao, C., Wang, X., Zhang, J., & Zhao, W. (2026) · Geriatrics · doi:10.3390/geriatrics11030068
Alucozai, D., & Kwo, E. (2026) · Journal of Xenobiotics · doi:10.3390/jox16030106
“The preference for early-morning cortisol sampling reflects the diurnal peak of HPA axis activity and is the timing endorsed by the Endocrine Society for screening adrenal insufficiency [36].”
Borresen, S. W., Hansen, S. B., Al-Jorani, H., Tei, R., Dreyer, A. F., Boesen, V. B., Bislev, L. S., Jørgensen, N. T., Jensen, R. C., Bjergstrøm, M. L. L., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-113110
Ozeki, T., Ito, S., Muto, Y., Nagase, F. N., Iwasaki, K., Ito, Y., Ikai, H., Yamamoto, M., Yokoyama-Kokuryo, W., & Fujita, Y. (2026) · CEN Case Reports · doi:10.1007/s13730-026-01143-0
Hwang, J. H., Park, H. S., Nam, S. M., Park, S. S., Kim, J. H., Kim, S. K., Park, C., & Kim, Y. H. (2026) · Pituitary · doi:10.1007/s11102-026-01702-9
“…and the replacement dose was adjusted if the cortisol level was below 8 µg/dL. Patients with a normal ACTH stimulation test result, defined as a peak cortisol level higher than 18 µg/dL [11, 16], and adequate postoperative cortisol levels do not receive perioperative corticosteroid supplementation.”
Heming, N., Baron, Ė., Müller, G., Badie, J., Préau, S., Siami, S., Pouplet, C., Berger, A., Damoisel, C., Argaud, L., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-119187
“…within 48 hours (moribund patients); (2) suspected or proven acute adrenal insufficiency (basal cortisol <5 µg/dL or peak cortisol <18 µg/dL) 22 23 ; (3) chronic adrenal insufficiency; (4) concomitant treatment that inhibits cortisol production; (5) septic shock (Sepsis-3 definition) 24 ;…”
Laboratory Evaluation of the Hypothalamic-Pituitary-Adrenal Axis
Greere, D., & Păun, D. L. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016109
Bouys, L., & Libé, R. (2026) · EMC - Traité de médecine AKOS · doi:10.1016/s1634-6939(25)50817-7
The Rise of Oncoendocrinology: How Modern Cancer Therapies Are Reshaping Endocrine Practice
Shapoo, N., Boma, N., Gotlieb, V., Mattana, J., Belokovskaya, R., & Franco, A. (2026) · Medical Sciences · doi:10.3390/medsci14030347
Adrenal Tuberculosis Presenting as Adrenal Crisis: A Rare Presentation of Common Disease
Fenta, B., SEMERE, A., Kurtaile, B. K., & Ketema, W. (2026) · Case Reports in Endocrinology · doi:10.1155/crie/9086526
Fichna, M., Rogowicz‐Frontczak, A., Komarowska, H., Fichna, P., Sowińska, A., & Ruchała, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9661229/v1
Çetin, S. K., Şıklar, Z., Özsu, E., Aycan, Z., Ceran, A., Şenyazar, G., Karaca, S. E., Abseyi, S. N., Demirtaş, Ş., & Berberoğlu, M. (2026) · Ankara Üniversitesi Tıp Fakültesi Mecmuası · doi:10.65092/autfm.1827711
Wang, J., He, S., Pang, X., & Zhang, W. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-04071-9
“In previously published literature, CAH has mainly been discussed from the perspective of endocrine diagnosis, chronic hormone replacement, and prevention or treatment of adrenal insufficiency [1–3, 6, 10, 11].”
Chiloiro, S., Vicari, A., Giampietro, A., Costanza, F., Calandrelli, R., Mattogno, P. P., D’Alessandris, Q. G., Gaudino, S., Marinis, L. D., Doglietto, F., et al. (2026) · Pituitary · doi:10.1007/s11102-026-01726-1
EndoBridge 2025: pearls and highlights
Yıldız, B. O., Armenti, M., Brandi, M. L., Carey, J., Carling, T., Ciudin, A., Dhatariya, K., Fountas, A., Frühbeck, G., Goulis, D. G., et al. (2026) · HORMONES · doi:10.1007/s42000-026-00804-0 · Cited by 1
Self-citation
Metadata
- Authors
- Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., & Torpy, D. J.
- Affiliations
- King's College London (GB)
- Mayo Clinic (US)
- National Institutes of Health (US)
- Royal Adelaide Hospital (AU)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-02
- Volume
- 101
- Issue
- 2
- Pages
- 364-389
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4880116
- OpenAlex
- W2234917292
- Cited by
- 1,769
- References
- 222
- Citations by year
- 2026: 187 · 2025: 198 · 2024: 180 · 2023: 191 · 2022: 180 · 2021: 206 · 2020: 165 · 2019: 149 · 2018: 148 · 2017: 102 · 2016: 54
- FWCI
- 151.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by-nc-nd)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- European Society of Endocrinology
- Novo Nordisk Fonden (NNF14OC0011005)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK062027)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- Addison's disease, diagnosis, hydrocortisone replacement, fludrocortisone, corticosteroid dose, stress dosing, 21-hydroxylase autoantibodies, autoimmune thyroid disease, pregnancy, glucocorticoid therapy, autoimmune adrenal insufficiency
- MeSH terms
- Adrenal Insufficiency, Female, Humans, Pregnancy, Societies, Medical, Evidence-Based Medicine, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.